Improved Ocular Tissue Models and Eye-On-A-Chip Technologies Will Facilitate Ophthalmic Drug Development

Journal of Ocular Pharmacology and Therapeutics - United States
doi 10.1089/jop.2018.0139
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Seeing Eye to Eye on Ophthalmic Regional Anesthesia

Anesthesiology
AnesthesiologyPain Medicine
2011English

Effect of a New Ophthalmic Hydrocortisone and Sodium Hyaluronate Formulation on Two Experimental Dry Eye Models

Acta Ophthalmologica
MedicineOphthalmology
2018English

Preeclampsia €“ Will Orphan Drug Status Facilitate Innovative Biological Therapies?

Frontiers in Surgery
Surgery
2015English

Enabling Technologies Facilitate New Healthcare Delivery Models for Acute Stroke

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2010English

Concise Review: Stem Cell Microenvironment on a Chip: Current Technologies for Tissue Engineering and Stem Cell Biology

Stem cells translational medicine
MedicineDevelopmental BiologyCell Biology
2015English

The Progress of BMP4 on the Role of Ocular Development and Eye Diseases

American Journal of Biochemistry and Biotechnology
BiochemistryBiotechnology
2017English

Human OA Model Technologies: “Joint-On-A-Chip”

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

The Prevalence of Ophthalmic Manifestations in COVID-19 and the Diagnostic Value of Ocular Tissue/Fluid

Graefe's Archive for Clinical and Experimental Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2020English

Treatise on Ocular Drug Delivery

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy